Bluestone Jeffrey
SEC CIK 1771814 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | Dir | 10.4K | — | $3.14M | 14 | 2021-12-08 | 2026-08-20 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-21 19:22 | 2026-08-20 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | $67.04 | +5,000 | 10.4K | +93% | +$335.2K |
| DMT | 2026-08-21 19:22 | 2026-08-20 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | S - Sale+OE | $145.02 | -5,000 | 10.1K | -33% | -$725.1K |
| D | 2026-05-04 16:40 | 2026-04-30 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | A - Grant | $0.00 | +1,146 | 10.1K | +13% | $0 |
| D | 2026-01-21 | 2026-01-20 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | $67.45 | +5,000 | 13.9K | +56% | +$337.2K |
| D | 2026-01-21 | 2026-01-20 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | S - Sale+OE | $123.50 | -5,000 | 8,920 | -36% | -$617.5K |
| D | 2025-12-01 | 2025-11-28 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | S - Sale+OE | $125.08 | -5,000 | 8,920 | -36% | -$625.4K |
| D | 2025-12-01 | 2025-11-28 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | $64.92 | +5,000 | 13.9K | +56% | +$324.6K |
| D | 2025-07-15 | 2025-07-14 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | $67.45 | +5,000 | 13.9K | +56% | +$337.2K |
| D | 2025-07-15 | 2025-07-14 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | S - Sale+OE | $109.74 | -5,000 | 8,920 | -36% | -$548.7K |
| D | 2024-11-27 | 2024-11-26 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | S - Sale+OE | $91.39 | -6,788 | 8,920 | -43% | -$620.4K |
| DM | 2024-11-27 | 2024-11-26 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | $61.24 | +10.0K | 11.6K | +630% | +$612.4K |
| D | 2022-05-06 | 2022-05-05 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | A - Grant | $0.00 | +2,444 | 5,708 | +75% | $0 |
| D | 2022-05-03 | 2022-05-03 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | — | +2,223 | 3,264 | +214% | — |
| D | 2021-12-09 | 2021-12-08 | GILD | Gilead Sciences | Bluestone Jeffrey | Dir | M - OptEx | — | +1,041 | 1,041 | New | — |
Purchase Sale Sale after option exercise All abbreviations